Moderator of 3 Sessions
Presenter of 3 Presentations
Diabetes Technology and Therapy in The Pediatric Age Group
Teamwork, targets, technology, and tight control (4T program): Personalized medicine at population scale, technical, financial, and advocacy challenges
Abstract
Abstract Body
Translation of optimal diabetes outcomes from the Diabetes Control and Complications Trial and diabetes technology research to routine clinical care has been suboptimal. The Stanford Pediatric Diabetes Team designed, implemented, and iterated on a pragmatic research study: ‘Teamwork, Targets, Technology, and Tight Control (4T Program)’ with the goal of improving care after diagnosis of type 1 diabetes in pediatric patients. We hypothesized that early introduction of CGM and systematic education combined with reducing the friction of CGM analysis to allow for more timely education interventions and dose adjustments would result in improved glucose metrics and quality of life. Pilot study data will be reviewed as well as approaches to technical and financial challenges to scaling the 4T program to a larger patient population in our clinic and to share the 4T program with other diabetes centers. Future directions include systematically implementing automated insulin delivery, scaling the 4T project to a wider population within our clinic and in collaboration with external colleagues, incorporating an exercise education sub-study, and advocating for better insurance coverage for diabetes care for all.
We would like to thank the other members of the 4T Study Group for their help with this project. Study team members include: Brianna Leverenz, BS, Julie Hooper MPH, RD, Ana Cortes, BS, Franziska Bishop, MS, CDCES, Natalie Pageler, MD, Jeannine Leverenz, RN, CDCES, Piper Sagan, RN, CDCES, Anjoli Martinez-Singh, RD, CDCES, Barry Conrad RD, CDCES, Annette Chmielewski, RD, CDCES, Julie Senaldi RN, CDCES, Nora Arrizon-Ruiz, Erica Pang, BS, Carolyn Herrera, BS, Victoria Ding, MS, Rebecca Gardner, MS, Kim Clash, NP, Erin Hodgson, RD, CDCES, Johannes Ferstad BS, Ryan Pie, MS, Michael Gao, BS, Annie Chang, BS, Simrat Ghuman, PhD, Priya Prahalad MD, Ananta Addala MD, Dessi Zaharieva PhD, Korey Hood PhD, Manisha Desai PhD, Ramesh Johari PhD, David Scheinker PhD and Esli Osmanlliu, MD
Experience in the United States
Abstract
Abstract Body
Diabetes technology has improved quality of life, increased time-in-range, and decreased hypoglycemia over the past decade. Healthcare in the US is inequitable, including care for people with diabetes. Recent data on disparities in diabetes technology use and outcomes will be reviewed. Local and national efforts to improve access to diabetes technology and to improve outcomes with the goal or reducing socioeconomic disparities will be described.
We would like to thank the other members of the 4T Study Group for their help with this project. Study team members include: Brianna Leverenz, BS, Julie Hooper MPH, RD, Ana Cortes, BS, Franziska Bishop, MS, CDCES, Natalie Pageler, MD, Jeannine Leverenz, RN, CDCES, Piper Sagan, RN, CDCES, Anjoli Martinez-Singh, RD, CDCES, Barry Conrad RD, CDCES, Annette Chmielewski, RD, CDCES, Julie Senaldi RN, CDCES, Nora Arrizon-Ruiz, Erica Pang, BS, Carolyn Herrera, BS, Victoria Ding, MS, Rebecca Gardner, MS, Kim Clash, NP, Erin Hodgson, RD, CDCES, Johannes Ferstad BS, Ryan Pie, MS, Michael Gao, BS, Annie Chang, BS, Simrat Ghuman, PhD, Priya Prahalad MD, Ananta Addala MD, Dessi Zaharieva PhD, Korey Hood PhD, Manisha Desai PhD, Ramesh Johari PhD, David Scheinker PhD and Esli Osmanlliu, MD